Search - tctmd.com

Displaying 661 - 680 of 1391

Sort: Relevancy | Date

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White

September 15, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White, Eun-Seok Shin

September 15, 2014

Presentation TCT 2014

Case #2: Complex Triple Vessel Disease with ACS and Diabetes

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White

September 15, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Oscar A. Mendiz, Gennaro Sardella, Stephen G. Worthley

September 15, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Oscar A. Mendiz, Gennaro Sardella, Stephen G. Worthley, Ugo Limbruno

September 15, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Oscar A. Mendiz, Gennaro Sardella, Stephen G. Worthley, Peter Barlis

September 15, 2014

Presentation TCT 2014

Case #1: STEMI: Primary PCI with Large Thrombus Burden

Presenter: Oscar A. Mendiz, Gennaro Sardella, Stephen G. Worthley, Ugo Limbruno

September 15, 2014

Presentation TCT 2014

TCT 467: Bivalirudin vs Heparin for Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Controlled Trials

Presenter: David J. Moliterno, E. Magnus Ohman, Duane S. Pinto, Michael Lipinski

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Rod H. Stables

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Gregg W. Stone

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Stefanie Schüpke

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Roxana Mehran

September 14, 2014

Presentation TCT 2014

Adjunct Pharmacotherapy for ACS and STEMI: 2014 Update

Presenter: Cindy L. Grines, Neal S. Kleiman

September 14, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

Presentation TCT 2014

STEMI Transfer Timing Strategies: Have We Maximized the Benefits?

Presenter: Cindy L. Grines, Neal S. Kleiman, Brahmajee K. Nallamothu

September 14, 2014

Presentation TCT 2014

SMILE: A Prospective, Randomized Trial of Single-Staged Versus Multistaged Coronary Intervention in Patients with NonST-Segment Elevation Myocardial Infarction and Multivessel Disease

Presenter: Steven R. Bailey, Gennaro Sardella

September 14, 2014

Presentation TCT 2014

Relationship Between Infarct Size and Subsequent Mortality Following Primary PCI for STEMI: A Pooled Patient Level Analysis From 10 Trials

Presenter: Steven R. Bailey, Gregg W. Stone

September 14, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Petr Kala, Josef Stasek, Alec S. Vahanian, Viliam Fridrich

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Petr Kala, Josef Stasek, Alec S. Vahanian, Stanislav Juhas

September 14, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Petr Kala, Josef Stasek, Alec S. Vahanian, Michael Zelizko

September 14, 2014

Advertisement

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #2: Complex Triple Vessel Disease with ACS and Diabetes

Consensus and Take-home Messages

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #1: STEMI: Primary PCI with Large Thrombus Burden

TCT 467: Bivalirudin vs Heparin for Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Controlled Trials

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

Adjunct Pharmacotherapy for ACS and STEMI: 2014 Update

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

STEMI Transfer Timing Strategies: Have We Maximized the Benefits?

SMILE: A Prospective, Randomized Trial of Single-Staged Versus Multistaged Coronary Intervention in Patients with NonST-Segment Elevation Myocardial Infarction and Multivessel Disease

Relationship Between Infarct Size and Subsequent Mortality Following Primary PCI for STEMI: A Pooled Patient Level Analysis From 10 Trials

Consensus and Take-home Messages

How Did I Treat This Patient?

How Would I Treat This Patient?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content